<p>SH-SY5Y neuroblastoma cells were treated with 250 nM TSA for 16 h. mRNA transcript levels of HMGCS, HMGCR, MVK, LDLR, SREBP1c and 2, APOE, NPC1, ABCA1 and CYP46A1 were analyzed by real-time RT-PCR. Values were normalized to the internal standard β-actin and expressed as fold change relative to untreated cells. Values represent means ± SEM from at least three individual experiments (* <i>p</i><0.05, ** <i>p</i><0.01, *** <i>p</i><0.001).</p
<p>Gene expression changes were analyzed for (<b>A</b>) <i>Hmgcs1</i>, (<b>B</b>) <i>Hmgcr</i>, (<b>...
(A) Cholesterol level was compared between benign and malignant breast cancer tissues. Equal weights...
<p>SK-MEL-23 and EB16-MEL cell lines were exposed to either 300 nM TSA during 24h (<i>A</i>), or 1 µ...
<p>SH-SY5Y neuroblastoma cells were pre-treated with 3 µg/ml U18666A for 6 h and with or without 250...
<p>SH-SY5Y neuroblastoma cells were treated with vehicle or 250 nM TSA for 16 h, or with 250 nM TSA ...
<p>A) Quantification of total cholesterol was performed in SH-SY5Y neuroblastoma cells treated with ...
<p>A) Western blot analysis of SREBP2 protein levels in SH-SY5Y cells after treatment with 250 nM TS...
<p><i>DKK1</i> mRNA level was analyzed in SW480 cells treated with 50, 100 or 200 nmol/L of TSA (TSA...
<p>(A) Total RNA was isolated from LNCaP cells treated with 200 nM and 400 nM TSA for 8, 16 and 24 h...
<p>A) Filipin III immunofluorescence staining of SH-SY5Y cells treated for the indicated time-points...
<p>PBMC were treated with 0.5 µM TSA for 24 h, with DMSO in the absence of TSA as control. Results a...
<p>Passage (P)1 hMSCs were grown in the presence of TSA (at 6.25 nM) or vehicle DMSO to passage 6. (...
<p>Total RNA was isolated from PC3 cells treated with 200 nM and 400 nM TSA (A) or 2.5 µM and 5 µM S...
<p>(<b>A</b>) RT-PCR for <i>Smn</i> and a known target of TSA, <i>follistatin</i>, was conducted in ...
<p>A) The effect of TSA treatment (250 ng/mL for 16 h) on the expression of <i>CXCL1</i>–<i>3</i>, <...
<p>Gene expression changes were analyzed for (<b>A</b>) <i>Hmgcs1</i>, (<b>B</b>) <i>Hmgcr</i>, (<b>...
(A) Cholesterol level was compared between benign and malignant breast cancer tissues. Equal weights...
<p>SK-MEL-23 and EB16-MEL cell lines were exposed to either 300 nM TSA during 24h (<i>A</i>), or 1 µ...
<p>SH-SY5Y neuroblastoma cells were pre-treated with 3 µg/ml U18666A for 6 h and with or without 250...
<p>SH-SY5Y neuroblastoma cells were treated with vehicle or 250 nM TSA for 16 h, or with 250 nM TSA ...
<p>A) Quantification of total cholesterol was performed in SH-SY5Y neuroblastoma cells treated with ...
<p>A) Western blot analysis of SREBP2 protein levels in SH-SY5Y cells after treatment with 250 nM TS...
<p><i>DKK1</i> mRNA level was analyzed in SW480 cells treated with 50, 100 or 200 nmol/L of TSA (TSA...
<p>(A) Total RNA was isolated from LNCaP cells treated with 200 nM and 400 nM TSA for 8, 16 and 24 h...
<p>A) Filipin III immunofluorescence staining of SH-SY5Y cells treated for the indicated time-points...
<p>PBMC were treated with 0.5 µM TSA for 24 h, with DMSO in the absence of TSA as control. Results a...
<p>Passage (P)1 hMSCs were grown in the presence of TSA (at 6.25 nM) or vehicle DMSO to passage 6. (...
<p>Total RNA was isolated from PC3 cells treated with 200 nM and 400 nM TSA (A) or 2.5 µM and 5 µM S...
<p>(<b>A</b>) RT-PCR for <i>Smn</i> and a known target of TSA, <i>follistatin</i>, was conducted in ...
<p>A) The effect of TSA treatment (250 ng/mL for 16 h) on the expression of <i>CXCL1</i>–<i>3</i>, <...
<p>Gene expression changes were analyzed for (<b>A</b>) <i>Hmgcs1</i>, (<b>B</b>) <i>Hmgcr</i>, (<b>...
(A) Cholesterol level was compared between benign and malignant breast cancer tissues. Equal weights...
<p>SK-MEL-23 and EB16-MEL cell lines were exposed to either 300 nM TSA during 24h (<i>A</i>), or 1 µ...